Hematologic malignancies in the medical intensive care unit – Outcomes and prognostic factors

References

• Brunet F, Lanore JJ, Dhainaut JF, Dreyfus F, Vaxelaire JF, Nouira S, et al. Is intensive care justified for patients with haematological malignancies? Intensive Care Med. 1990;16:291–7.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Recher C, Alberti C, Soufir L,, Leleu G, Le Gall JR, et al. Changing use of intensive care for hematological patients: the example for hematological patients: the example of multiple myeloma. Intensive Care Med. 1999;25:1395–401.
   PubMed Web of Science ®Google Scholar
• Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med. 2003;31:104–12.
   PubMed Web of Science ®Google Scholar
• Cuthbertson BH, Rajalingham Y, Harrison S, McKirdy F. The outcome of haematological malignancy in Scottish intensive care units. J Intensive Care Soc. 2008;9:135–40.
   Google Scholar
• Rees JKH, Gray RG, Wheatley K. Dose intensification in acute myleiod leukaemia: greater effectiveness at lower cost. Principal report of the medical research council's AML9 study. Br J Haematol. 1996;94:89–98.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Afessa B. The intensive care support of patients with malignancy: do everything that can be done. Intensive Care Med. 2006;32:3–5.
   PubMed Web of Science ®Google Scholar
• Hampshire PA, Welch CA, McCrossan LA, Francis K, Harrison DA. Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care. 2009;13:R137.
   PubMed Web of Science ®Google Scholar
• Crawford SW, Petersen FB. Long-term survival from respiratory failure after marrow transplantation for malignancy. Am Rev Respir Dis. 1992;145:510–4.
   PubMed Web of Science ®Google Scholar
• Khassawneh BY, White P Jr, Anaissie EJ, Barlogie B, Hiller FC. Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest. 2002;121:185–8.
   PubMed Web of Science ®Google Scholar
• Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG. Outcome of recipients of bone marrow transplants who required intensive care unit support. Mayo Clin Proc. 1992;67:117–22.
   PubMed Web of Science ®Google Scholar
• Yau E, Rohatiner AZ, Lister TA, Hinds CJ. Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy. Br J Cancer. 1992;64:938–42.
   Web of Science ®Google Scholar
• Owczuk R, Wujtewicz MA, Sawicka W, Wadrzyk A, Wujtewicz M. Patients with haematological malignancies requiring invasive mechanical ventilation: differences between survivors and nonsurvivors in intensive care unit. Support Care Cancer. 2005;13:332–8.
   PubMed Web of Science ®Google Scholar
• Evison J, Rickenbacher P, Ritz R, Gratwohl A, Hoberthür C, Elasser S, et al. Intensive care unit admission in patients with haematological disease: incidence, outcome and prognostic factors. Swiss Med Wkly. 2002;131:681–6.
   Web of Science ®Google Scholar
• Lamia B, Hellot M, Girault C, Tamion F, Dachraoui F, Lenain P, et al. Changes in severity and organ failure scores as prognostic factors in oncohematological malignancy patients admitted to the ICU. Intensive Care Med. 2006;32:1560–8.
   PubMed Web of Science ®Google Scholar
• Kroschinsky F, Weise M, Illmer T, Haenel M, Bornhaeuser M, Hoeffken G, et al. Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med. 2002;28:1294–300.
   PubMed Web of Science ®Google Scholar
• Geerse DA, Span LF, Pinto-Sietsma SJ, van Mook WN. Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality. Eur J Intern Med. 2011;22:57–61.
   PubMed Web of Science ®Google Scholar
• Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296–327.
   PubMed Web of Science ®Google Scholar
• Gasparovic V, Filipovic-Greie I, Merkler M, Pisl Z. Continuousrenal replacement therapy (CRRT) or intermittent hemodialysis (IHD)—what is the procedure of choice in critically ill patients? Ren Fail. 2003;25:855–62.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Albertti C, Bronstain C, Leleu G, Moreau D, Recher C, et al. Improved survival in cancer patients requiring mechanical ventilatiory support: impact of noninvasive mechanical ventilator support. Crit Care Med. 2001;29:519–25.
   PubMed Web of Science ®Google Scholar
• Staudinger T, Stoiser B, Mullner M, Locker GJ, Laczika K, Knapp S, et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med. 2000;28:1322–8.
   PubMed Web of Science ®Google Scholar
• Depuydt PO, Benoit DD, Vendewoude K, Decruyenaere J, Colardyn F. Outcome in non-invasively and invasively ventilated hematologic patients with acute respiratory failure. Chest. 2004;126:1299–306.
   PubMed Web of Science ®Google Scholar
• Lloyd-Thomas AR, Wright I, Liter TA, Hinds CJ. Prognosis of patients receiving intensive care for life-threatening medical complications of hematological malignancy. BMJ 1988;296:1025–9.
   PubMed Web of Science ®Google Scholar
• Hinds CJ, Martin R, Quinton P. Intensive care for patients with medical complications of hematologic malignancy: is it worth it? Schweiz Med Wochenschr. 1998;128:1467–73.
   PubMedGoogle Scholar
• Larche J, Azouley E, Fieux F, Mesnard L, Moreau D, Thiery G, et al. Improved survival of critically ill cancer patients with septic shock. Intensive Care Med. 2003;29:1688–95.
   PubMed Web of Science ®Google Scholar
• Bird GT, Farquhar-Smith P, Wigmore T, Potter M, Gruber PC. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 year study. Br J Anaesth. 2012;108:452–9.
   PubMed Web of Science ®Google Scholar
• Massion PB, Dive AM, Doyen C, Bulpa P, Jamart J, Bosly A, et al. Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med. 2002;30:2260–70.
   PubMed Web of Science ®Google Scholar
• Price KJ, Cardenas-Turanzas M, Lin H, Roden L, Nigam R, Nates JL. Prognostic indicators of mortality of mechanically ventilated patients with acute leukemia in a comprehensive cancer center. Minerva Anestesiol. 2013;79:147–55.
   PubMed Web of Science ®Google Scholar
• Adda M, Coquet I, Darmon M, Thierry G, Schlemmer B, Azoulay E. Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure. Crit Care Med. 2008;36(10):2766–72.
   PubMed Web of Science ®Google Scholar
• Pene F, Aubron C, Azoulay E, Blot F, Thiery G, Raynard B, et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol. 2006;23:643–9.
   Google Scholar
• Poletti V, Trisolini R, Tura S. Pulmonary disease in patients with hematologic malignancies. Sarcoidosis Vasc Diffuse Lung Dis. 2002;191:29–45.
   Google Scholar
• Antonelli M, Conti G, Bufi M,, Costa MG, Lappa A, Rocco M, et al. Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial. JAMA. 2000;283:235–41.
   PubMed Web of Science ®Google Scholar
• Hibert G, Gruson D, Vargas D, Valentino R, Gbikpi-Benissan G, Dupon M, et al. Noninvasive ventilation in immunosupressed patients with pulmonary infiltrates, fever and acute respiratory failure. N Engl J Med. 2001;344:481–7.
   PubMed Web of Science ®Google Scholar
• Gruson D, Hilbert G, Valentino R, Vargas F, Chene G, Bebear C, et al. Utility of fiberoptic bronchoscopy in neutropenic patients admitted to the intensive care unit with pulmonary infiltrates. Crit Care Med. 2000;28:2224–30.
   PubMed Web of Science ®Google Scholar
• Antonelli M, Conti G, Rocco M, Arcangeli A, Cavaliere F, Proietti R, et al. Noninvasive positive pressure ventilation vs conventional oxygen supplementation in hypoxemic patients undergoing diagnostic bronchoscopy. Chest. 2002;121:1149–54.
   PubMed Web of Science ®Google Scholar
• Namendys-Silva SA, Gonzales-Herrera MO, Garcia-Guillen FJ, Txcocano-Becerra J, Herrera-Gomez A. Outcome of critically ill patients with hematological malignancies. Ann Hematol. 2013;92:699–705.
   PubMed Web of Science ®Google Scholar
• Molina R, Bernal T, Borges M, Zaragoza R, Bonastre J, Granada RM, et al. Ventilatory support in critically ill hematology patients with respiratory failure. Crit Care. 2012;16:R133.
   PubMed Web of Science ®Google Scholar
• Wermke M, Sheimanck S, Hoffken G, Ehninger G, Bornhauser M, Illmer T. Respiratory failure in patients undergoing allogeneic hematopoietic SCT-a randomized trial on early non-invasive ventilation based on standard care hematology wards. Bone Marrow Transplant. 2012;37:574–80.
   Google Scholar
• Souza-Dantas VC, Salluh JI, Soares M. Impact of neutropenia on the outcomes of critically ill patients with cancer: a matched case-control study. Ann Oncol. 2011;22:2094–100.
   PubMed Web of Science ®Google Scholar
• Labar B, Bogdanić V, Nemet D, Mrsic M, Pavletic Z, Zupancic S, et al. Allogeneic BMT for AML in Zagreb. Bone Marrow Transplant. 1989;4:86–7.
   PubMed Web of Science ®Google Scholar